【Rongchang organismLast year, Hong Kong shares listed as the world's largest biomedical IPO] Rongchang Biopharmaceutical (Yantai) Co., Ltd. signed a listing guidance agreement with Huatai United Securities on March 2, and recently put A shares on record in Shandong Securities Regulatory Bureau, intending to list A shares. This means that Rongchang, which has just been listed in Hong Kong for four months and created the world's largest biomedical IPO in 2020, has officially launched a secondary listing of A shares. (IPO knew)
荣昌生物启动辅导拟A股二次上市,去年港股上市曾创当年全球最大生物医药IPO
Rongchang biological startup counseling plans to make a secondary listing of A shares. Last year, the listing of Hong Kong shares created the world's largest biomedical IPO at that time.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.